Darby Thomas, PhD
Scientific Director, Cell & Gene Therapies
Darby Thomas, PhD, is the Scientific Director of Cell & Gene Therapies. She earned her PhD in Molecular Virology from Baylor College of Medicine, performed postdoctoral training at the University of Pennsylvania, followed by 17 years in industry prior to joining Fortrea (formerly Labcorp) in 2021.
Dr. Thomas has broad experience in adeno-associated virus (AAV) gene therapy with roles in CMC, discovery, translational development, and patient advocacy for several AAV-focused companies with an emphasis on rare neurological and metabolic diseases and ophthalmology. She also has translational experience developing plasmid-based gene therapies, lentiviruses, as well as gene-modified cell therapies for the treatment of rare skin disorders.
Dr. Thomas provides specialized scientific expertise providing leadership and guidance to integrated global teams, as well as internal and external consultation and training on cell and gene therapy programs.